Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Annick Clement (Paris, France). Chronic interstitial lung disease in children: diagnosis and treatment. International Congress 2016 – PG6 Lung fibrosis and sarcoidosis

Member's Comments

No comment yet.

Related content which might interest you: Chronic interstitial lung in children: diagnosis and treatment Source: International Congress 2015 – PG17 Lung fibrosis and sarcoidosis Year: 2015 Chronic interstitial lung disease in children Source: International Congress 2017 – Paediatric year in review: update on paediatric pulmonology Year: 2017 Chronic interstitial lung disease in children Source: Eur Respir Rev, 27 (147) 170100; 10.1183/16000617.0100-2017 Year: 2018 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018 Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Interstitial lung diseases in childhood Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=213 Year: 2002 Childhood interstitial lung disease: A diagnostic challenge Source: International Congress 2015 – Connective tissue disorders Year: 2015 Task force on chronic interstitial lung disease in immunocompetent children Source: Eur Respir J 2004; 24 : 686-697 Year: 2004 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Clues beyond the lung: an unusual diagnosis in an infant with chronic lung disease Source: Breathe, 16 (1) 190319; 10.1183/20734735.0319-2019 Year: 2020 Can HSP27 and HSP70 be used as biomarkers for chronic obstructive pulmonary disease diagnosis? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Impact of COVID-19 on patients with chronic lung disease Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Long-term treatment with nintedanib in patients with IPF: An update from INPULSIS®-ON Source: International Congress 2016 – IPF treatment II Year: 2016